236 related articles for article (PubMed ID: 23507021)
1. The vasoactive-inotropic score and levosimendan: time for LVIS?
Favia I; Vitale V; Ricci Z
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e15-6. PubMed ID: 23507021
[No Abstract] [Full Text] [Related]
2. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
3. Patients with advanced heart failure and the effects of levosimendan.
Song ZZ; Ma J
Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
[No Abstract] [Full Text] [Related]
4. Perioperative use of levosimendan: best practice in operative settings.
Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687
[No Abstract] [Full Text] [Related]
5. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
Pagel PS
Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
[No Abstract] [Full Text] [Related]
7. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan use in several scenarios of acute heart failure.
Tavares M; Andrade AC; Mebazaa A
Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
[TBL] [Abstract][Full Text] [Related]
9. Tricuspid valve replacement and levosimendan.
Cicekcioglu F; Parlar AI; Altinay L; Yay K; Katircioglu SF
Gen Thorac Cardiovasc Surg; 2008 Nov; 56(11):559-62. PubMed ID: 19002757
[TBL] [Abstract][Full Text] [Related]
10. First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
Osthaus WA; Boethig D; Winterhalter M; Huber D; Goerler H; Sasse M; Sümpelmann R
Eur J Pediatr; 2009 Jun; 168(6):735-40. PubMed ID: 18813947
[TBL] [Abstract][Full Text] [Related]
11. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
13. How to treat acute decompensated heart failure in the 'beta-blocker era'?
Marcondes-Braga FG; Mangini S; Ayub-Ferreira SM; Bocchi EA; Bacal F
Eur J Heart Fail; 2010 Aug; 12(8):893-4. PubMed ID: 20675672
[No Abstract] [Full Text] [Related]
14. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
Bredin F; Franco-Cereceda A
Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan for low cardiac output: a pediatric experience.
Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
[TBL] [Abstract][Full Text] [Related]
16. Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
Rafiq I; Freeman LJ
Int J Cardiol; 2015 Sep; 195():283-4. PubMed ID: 26056958
[No Abstract] [Full Text] [Related]
17. A struggle to SURVIVE: to abandon or not to abandon levosimendan?
Butler J; Giamouzis G; Giannakoulas G
Cardiovasc Drugs Ther; 2007 Oct; 21(5):401-2. PubMed ID: 17701453
[No Abstract] [Full Text] [Related]
18. Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.
Papoff P; Caresta E; Versacci P; Pinto R; Moretti C; Midulla F
Pediatr Emerg Care; 2012 Oct; 28(10):1062-5. PubMed ID: 23034494
[TBL] [Abstract][Full Text] [Related]
19. Advances in positive inotropic therapy: levosimendan.
Frishman WH
Crit Care Med; 2003 Sep; 31(9):2408-9. PubMed ID: 14501979
[No Abstract] [Full Text] [Related]
20. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Follath F; Franco F; Cardoso JS
Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
